About Us

About Temad Co.

TemadCo,(Active Pharmaceutical Ingredients), is member of TaminPharmaceutical Investment Company (TPICO) from SSIC SHASTA Group.Temad Co. Active Pharmaceutical Ingredients manufacturer, was established in 1980 as one of the largest producers of APIs in Iran and  an innovative manufacturer of  Narcotics and Non-Narcotics of world class quality in the Middle East. Apart from compliance with Iranian GMP regulations, Temad Co has acquired the national and international standards of API’s manufacturing such as ISO 9001, ISO14001, ISO 45001 and Food & Drug Administration withcertifying bodies in Europe , is also anticipating the CEP certificate from European organization. Temad Co. is one of  a pioneer pharmaceutical manufacturing company that is using its own qualified raw materials in finished dosage form manufacturing lines. At present, the company has 21 production lines and more than 115 pharmaceutical products including narcotics and general APIs in different forms such as DC grade API, pellets and non-sterile injectable grade.  Temad Co. as knowledge-based company and prominent national exporter in 2022 has employed 570 experienced, committed and responsible human resources to fulfill long term and high attitude approaches.

Manufacturing Facilities

  • Alborz Manufacturing Site

Alborz manufacturing site is located in an industrial zone 28th km of  the capital, Alborz, in a total area of about 4.2 hectare. This area includes production sites of 7170 m a warehouse is of 3450 m  and an administrative and laboratory area of 4450 m  .Temad facilities include high quality equipment with large capacity (more than300,000 L) glass-lines, stainless steel reactors and distillation units.

  • Mashhad Manufacturing Site

Mashhad manufacturing site is located in the 3rd km of Mashhad-Fariman road in Khorasan Razavi prouince in total area of about 11 Hectares. Total capacity of Mashhad Temad facilities is about 150,000 L glass lined, stainless steel reactors and distillation units.

Mashhad’s site, an API’s division of Temad , is the highly privileged producer of Paracetamol Powder and DC by employing high quality and experienced staff which not only has broughtcustomer satisfaction in the local market but also exports its products to the international markets

  • Quality Control

The quality control laboratory is equipped with the most advanced chemical analysis and identification apparates and equipments, which include HPLC, GC, FT-IR, Spectrophotometer, UV-VIS ,IMS, Atomic Absorption ,TLC Scanner and Laser Particle Size Analyzer. Stringent quality control procedures ensure products of the highest quality as an oblgation to the customers.

 

 

Temad Company Vision

By 2027 (1406 AH), Temad aims to become a knowledge-based, efficient, export-oriented, and leading company in producing high-quality active pharmaceutical ingredients (API) and semi-finished pharmaceutical products in Western Asia.

Mission Statement

Temad, as a knowledge-based company and a subsidiary of the TPICO pharmaceutical group, is dedicated to producing intermediates, active pharmaceutical ingredients (API), semi-finished products, and high-quality pharmaceutical formulations in the field of public health. The company focuses its diverse product portfolio on competitive quality and, leveraging cutting-edge global technology, aims to make a significant presence not only in Iran but also in international markets.

In this endeavor, Temad relies on its skilled and specialized human resources, motivated and committed to organizational values, prioritizing productivity enhancement. By creating sustainable added value for stakeholders, the company plays an essential role in lean production, ensuring pharmaceutical security, and achieving self-sufficiency in the nation’s pharmaceutical industry.

 

Organizational Values

1998
Company Establishment
Company Establishment

December 18, 1996 , registered under number 129211 at the Tehran Office of Company and Non-Commercial Institution Registration.

2002
Listing on the Tehran Stock Exchange
Listing on the Tehran Stock Exchange

It was listed on the Tehran Stock Exchange on November 24, 2002.

2017
Production of Finished Products
Production of Finished Products

Entry into the field of finished product manufacturing

2019
Enhancing position in the pharmaceutical industry
Enhancing position in the pharmaceutical industry

First rank in the export of pharmaceutical active ingredients in Iran

2020
The company's most recent capital increase
The company's most recent capital increase

The company's most recent capital increase was a 39% rise, growing from 360 billion to 500 billion Rials.

2023
Enhancing rank in the Middle Eas
Enhancing rank in the Middle Eas

Achieving the top position in the Active Pharmaceutical Ingredients (API) production industry and enhancing rank in the Middle East pharmaceutical industry.

2027
Vision
Vision

It will be a knowledge-based, efficient, export-oriented, and leading company in the production of high-quality active pharmaceutical ingredients (API) and semi-finished products in Western Asia.

Export to five continents

0Export Destination
0Exports Products
0million dollars of 2023 exports